We have located links that may give you full text access.
Time in Therapeutic Range for Targeted Temperature Management and Outcomes Following Out-of-Hospital Cardiac Arrest.
Resuscitation 2022 November 26
OBJECTIVE: For comatose survivors of out-of-hospital cardiac arrest (OHCA), current guidelines recommend targeted temperature management (TTM) with a goal temperature of 32°C - 36°C for at least 24 hours. We examined adherence to temperature targets, quantified as time-in-therapeutic range (TTR), and association of TTR with survival and neurologic outcomes.
METHODS: We conducted a retrospective cohort study of the Resuscitation Outcomes Consortium-Continuous Chest Compressions trial, including adults with OHCA who underwent TTM for >12 hours. We imputed continuous temperatures between consecutive temperature measurements using the linear interpolation method and calculated TTR for multiple target temperatures. The association of TTR with survival to hospital discharge and favorable neurological outcome was evaluated using hierarchical regression models.
MAIN RESULTS: Among 2,637 patients (mean age 62.3 years, 29.9% female), the median duration of TTR for TTM between 32°C - 36°C was 23 (IQR: 21-24) hours with a median time outside therapeutic range of 0.9 (IQR: 0.0 - 4.2) hours. In risk-adjusted analyses, there was no association of TTR of 32°C - 36°C with overall survival (OR 1.00 [95% CI, 0.90 - 1.10]) or favorable neurologic outcome (1.02 [95% CI, 0.90 - 1.14]). However, in assessments of TTR 33°C - 36°C, there was a significant association with favorable neurologic survival (OR 1.12 [1.01 - 1.25]) but not overall survival (OR 1.04 [0.94 - 1.15]).
CONCLUSIONS: Among patients with OHCA who underwent TTM, we found variability in adherence to guideline-recommended treatment targets. Higher TTR was not associated with overall survival, but for certain temperature thresholds, TTR was associated with favorable neurologic outcome.
METHODS: We conducted a retrospective cohort study of the Resuscitation Outcomes Consortium-Continuous Chest Compressions trial, including adults with OHCA who underwent TTM for >12 hours. We imputed continuous temperatures between consecutive temperature measurements using the linear interpolation method and calculated TTR for multiple target temperatures. The association of TTR with survival to hospital discharge and favorable neurological outcome was evaluated using hierarchical regression models.
MAIN RESULTS: Among 2,637 patients (mean age 62.3 years, 29.9% female), the median duration of TTR for TTM between 32°C - 36°C was 23 (IQR: 21-24) hours with a median time outside therapeutic range of 0.9 (IQR: 0.0 - 4.2) hours. In risk-adjusted analyses, there was no association of TTR of 32°C - 36°C with overall survival (OR 1.00 [95% CI, 0.90 - 1.10]) or favorable neurologic outcome (1.02 [95% CI, 0.90 - 1.14]). However, in assessments of TTR 33°C - 36°C, there was a significant association with favorable neurologic survival (OR 1.12 [1.01 - 1.25]) but not overall survival (OR 1.04 [0.94 - 1.15]).
CONCLUSIONS: Among patients with OHCA who underwent TTM, we found variability in adherence to guideline-recommended treatment targets. Higher TTR was not associated with overall survival, but for certain temperature thresholds, TTR was associated with favorable neurologic outcome.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app